Logo image of SNEX

STONEX GROUP INC (SNEX) Stock Fundamental Analysis

NASDAQ:SNEX - Nasdaq - US8618961085 - Common Stock - Currency: USD

87.61  +1.62 (+1.88%)

Premarket: 87.85 +0.24 (+0.27%)

Fundamental Rating

3

Overall SNEX gets a fundamental rating of 3 out of 10. We evaluated SNEX against 230 industry peers in the Capital Markets industry. SNEX may be in some trouble as it scores bad on both profitability and health. SNEX is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year SNEX was profitable.
SNEX had a negative operating cash flow in the past year.
Each year in the past 5 years SNEX has been profitable.
The reported operating cash flow has been mixed in the past 5 years: SNEX reported negative operating cash flow in multiple years.
SNEX Yearly Net Income VS EBIT VS OCF VS FCFSNEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

The Return On Assets of SNEX (0.90%) is worse than 70.00% of its industry peers.
SNEX has a Return On Equity of 15.04%. This is in the better half of the industry: SNEX outperforms 75.22% of its industry peers.
With a Return On Invested Capital value of 1.57%, SNEX is not doing good in the industry: 66.52% of the companies in the same industry are doing better.
Measured over the past 3 years, the Average Return On Invested Capital for SNEX is significantly below the industry average of 7.08%.
Industry RankSector Rank
ROA 0.9%
ROE 15.04%
ROIC 1.57%
ROA(3y)0.99%
ROA(5y)0.96%
ROE(3y)16.74%
ROE(5y)16.85%
ROIC(3y)2.05%
ROIC(5y)1.73%
SNEX Yearly ROA, ROE, ROICSNEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

SNEX's Profit Margin of 0.25% is on the low side compared to the rest of the industry. SNEX is outperformed by 73.91% of its industry peers.
SNEX's Profit Margin has been stable in the last couple of years.
With a Operating Margin value of 0.34%, SNEX is not doing good in the industry: 73.04% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of SNEX has remained more or less at the same level.
The Gross Margin of SNEX (2.17%) is worse than 70.87% of its industry peers.
In the last couple of years the Gross Margin of SNEX has declined.
Industry RankSector Rank
OM 0.34%
PM (TTM) 0.25%
GM 2.17%
OM growth 3Y-1.36%
OM growth 5Y1.16%
PM growth 3Y-1.69%
PM growth 5Y-0.17%
GM growth 3Y-15.32%
GM growth 5Y-4.82%
SNEX Yearly Profit, Operating, Gross MarginsSNEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3 4

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, SNEX has more shares outstanding
SNEX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for SNEX is higher compared to a year ago.
SNEX Yearly Shares OutstandingSNEX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
SNEX Yearly Total Debt VS Total AssetsSNEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

SNEX has an Altman-Z score of 3.47. This indicates that SNEX is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of SNEX (3.47) is better than 79.57% of its industry peers.
A Debt/Equity ratio of 6.63 is on the high side and indicates that SNEX has dependencies on debt financing.
The Debt to Equity ratio of SNEX (6.63) is worse than 86.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 6.63
Debt/FCF N/A
Altman-Z 3.47
ROIC/WACCN/A
WACCN/A
SNEX Yearly LT Debt VS Equity VS FCFSNEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

SNEX has a Current Ratio of 0.58. This is a bad value and indicates that SNEX is not financially healthy enough and could expect problems in meeting its short term obligations.
SNEX has a Current ratio of 0.58. This is in the lower half of the industry: SNEX underperforms 72.61% of its industry peers.
SNEX has a Quick Ratio of 0.58. This is a bad value and indicates that SNEX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.58, SNEX is not doing good in the industry: 72.61% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.58
Quick Ratio 0.58
SNEX Yearly Current Assets VS Current LiabilitesSNEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 14.92% over the past year.
Measured over the past years, SNEX shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.13% on average per year.
SNEX shows a strong growth in Revenue. In the last year, the Revenue has grown by 60.57%.
SNEX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.87% yearly.
EPS 1Y (TTM)14.92%
EPS 3Y26.7%
EPS 5Y22.13%
EPS Q2Q%19.25%
Revenue 1Y (TTM)60.57%
Revenue growth 3Y32.92%
Revenue growth 5Y24.87%
Sales Q2Q%16.72%

3.2 Future

Based on estimates for the next years, SNEX will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.25% on average per year.
SNEX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.15% yearly.
EPS Next Y11.71%
EPS Next 2Y5.9%
EPS Next 3Y8.25%
EPS Next 5YN/A
Revenue Next Year8.61%
Revenue Next 2Y5.95%
Revenue Next 3Y8.15%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SNEX Yearly Revenue VS EstimatesSNEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B 80B
SNEX Yearly EPS VS EstimatesSNEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 15.70, the valuation of SNEX can be described as correct.
The rest of the industry has a similar Price/Earnings ratio as SNEX.
SNEX is valuated rather cheaply when we compare the Price/Earnings ratio to 28.78, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 14.72, the valuation of SNEX can be described as correct.
The rest of the industry has a similar Price/Forward Earnings ratio as SNEX.
SNEX's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.32.
Industry RankSector Rank
PE 15.7
Fwd PE 14.72
SNEX Price Earnings VS Forward Price EarningsSNEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

SNEX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. SNEX is cheaper than 88.26% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.73
SNEX Per share dataSNEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 1K 1.5K 2K

4.3 Compensation for Growth

SNEX's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.34
PEG (5Y)0.71
EPS Next 2Y5.9%
EPS Next 3Y8.25%

0

5. Dividend

5.1 Amount

SNEX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

STONEX GROUP INC

NASDAQ:SNEX (4/25/2025, 8:00:01 PM)

Premarket: 87.85 +0.24 (+0.27%)

87.61

+1.62 (+1.88%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-05 2025-02-05/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners81.71%
Inst Owner Change5.81%
Ins Owners9.72%
Ins Owner Change13.72%
Market Cap4.22B
Analysts87.5
Price Target84.66 (-3.37%)
Short Float %N/A
Short Ratio2.8
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.88%
Min EPS beat(2)10.95%
Max EPS beat(2)14.81%
EPS beat(4)4
Avg EPS beat(4)7.91%
Min EPS beat(4)2.44%
Max EPS beat(4)14.81%
EPS beat(8)7
Avg EPS beat(8)10.04%
EPS beat(12)11
Avg EPS beat(12)19.49%
EPS beat(16)13
Avg EPS beat(16)17.59%
Revenue beat(2)1
Avg Revenue beat(2)-0.89%
Min Revenue beat(2)-3.69%
Max Revenue beat(2)1.92%
Revenue beat(4)2
Avg Revenue beat(4)-4.97%
Min Revenue beat(4)-24.32%
Max Revenue beat(4)6.22%
Revenue beat(8)5
Avg Revenue beat(8)-0.85%
Revenue beat(12)9
Avg Revenue beat(12)1500.64%
Revenue beat(16)13
Avg Revenue beat(16)2132.63%
PT rev (1m)-35.16%
PT rev (3m)-25.23%
EPS NQ rev (1m)0.47%
EPS NQ rev (3m)-30.55%
EPS NY rev (1m)0.21%
EPS NY rev (3m)-27.72%
Revenue NQ rev (1m)0.21%
Revenue NQ rev (3m)6.32%
Revenue NY rev (1m)3.31%
Revenue NY rev (3m)6.84%
Valuation
Industry RankSector Rank
PE 15.7
Fwd PE 14.72
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B 2.37
P/tB 2.49
EV/EBITDA 8.73
EPS(TTM)5.58
EY6.37%
EPS(NY)5.95
Fwd EY6.79%
FCF(TTM)-3.94
FCFYN/A
OCF(TTM)-2.56
OCFYN/A
SpS2249.12
BVpS36.93
TBVpS35.12
PEG (NY)1.34
PEG (5Y)0.71
Profitability
Industry RankSector Rank
ROA 0.9%
ROE 15.04%
ROCE 5.67%
ROIC 1.57%
ROICexc 1.71%
ROICexgc 1.86%
OM 0.34%
PM (TTM) 0.25%
GM 2.17%
FCFM N/A
ROA(3y)0.99%
ROA(5y)0.96%
ROE(3y)16.74%
ROE(5y)16.85%
ROIC(3y)2.05%
ROIC(5y)1.73%
ROICexc(3y)2.29%
ROICexc(5y)1.95%
ROICexgc(3y)2.5%
ROICexgc(5y)2.13%
ROCE(3y)6.36%
ROCE(5y)5.86%
ROICexcg growth 3Y11.83%
ROICexcg growth 5Y4.45%
ROICexc growth 3Y11.82%
ROICexc growth 5Y4.25%
OM growth 3Y-1.36%
OM growth 5Y1.16%
PM growth 3Y-1.69%
PM growth 5Y-0.17%
GM growth 3Y-15.32%
GM growth 5Y-4.82%
F-Score2
Asset Turnover3.66
Health
Industry RankSector Rank
Debt/Equity 6.63
Debt/FCF N/A
Debt/EBITDA 26.32
Cap/Depr 79.07%
Cap/Sales 0.06%
Interest Coverage 0.29
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.58
Quick Ratio 0.58
Altman-Z 3.47
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)80.55%
Cap/Depr(5y)85.05%
Cap/Sales(3y)0.07%
Cap/Sales(5y)0.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.92%
EPS 3Y26.7%
EPS 5Y22.13%
EPS Q2Q%19.25%
EPS Next Y11.71%
EPS Next 2Y5.9%
EPS Next 3Y8.25%
EPS Next 5YN/A
Revenue 1Y (TTM)60.57%
Revenue growth 3Y32.92%
Revenue growth 5Y24.87%
Sales Q2Q%16.72%
Revenue Next Year8.61%
Revenue Next 2Y5.95%
Revenue Next 3Y8.15%
Revenue Next 5YN/A
EBIT growth 1Y13.48%
EBIT growth 3Y31.11%
EBIT growth 5Y26.32%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-113.89%
FCF growth 3Y-40.15%
FCF growth 5Y19.18%
OCF growth 1Y-108.7%
OCF growth 3Y-37.96%
OCF growth 5Y20.98%